Failed Alzheimer’s Treatment Causes Stocks to Plunge

Failed Alzheimer’s Treatment Causes Stocks to Plunge

Eli Lilly and Co. have announced that their experimental Alzheimer’s treatment has failed to slow mental deterioration in its latest study. Consequently, Lilly shares dropped 11.7 percent on Wednesday. The announcement also caused a 4.3 percent drop in Biogen shares....
%d bloggers like this: